1 – 14 of 14
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Hepatitis C treatment at a Swedish needle exchange program, a successful model of care – the ACTIONNE study
(
- Contribution to journal › Article
- 2020
-
Mark
High risk of non-alcoholic liver disease mortality in patients with chronic hepatitis C with illicit substance use disorder
(
- Contribution to journal › Article
- 2019
-
Mark
Risk and outcome of hepatocellular carcinoma in liver cirrhosis in Southern Sweden : a population-based study
(
- Contribution to journal › Article
-
Mark
Persistent elevation of fibrosis biomarker cartilage oligomeric matrix protein following hepatitis C virus eradication
(
- Contribution to journal › Article
- 2018
-
Mark
Increased hope following successful treatment for hepatitis C infection
(
- Contribution to journal › Article
- 2017
-
Mark
Death from liver disease in a cohort of injecting opioid users in a Swedish city in relation to registration for opioid substitution therapy
(
- Contribution to journal › Article
- 2012
-
Mark
Needlestick injuries in European nurses in diabetes
(
- Contribution to journal › Article
- 2009
-
Mark
Health-related quality of life in patients with different stages of liver disease induced by hepatitis C
(
- Contribution to journal › Article
- 2007
-
Mark
Long-term follow-up of the hepatitis CHENCORE cohort: response to therapy and occurrence of liver-related complications
(
- Contribution to journal › Article
- 2005
-
Mark
Partial splenic embolization as pretreatment for antiviral therapy in hepatitis C virus infection
(
- Contribution to journal › Article
- 2001
-
Mark
Clinical spectrum of hepatitis C-related liver disease and response to treatment with interferon and ribavirin in haemophilia or von Willebrand disease
(
- Contribution to journal › Article
- 1998
-
Mark
Factors associated with cirrhosis development in chronic hepatitis C patients from an area of low prevalence
(
- Contribution to journal › Article
- 1997
-
Mark
Chronic non-A, non-B, non-C hepatitis: is hepatitis G/GBV-C involved?
(
- Contribution to journal › Article
- 1996
-
Mark
Factors influencing the response to interferon therapy in chronic hepatitis C. Studies on viral genotype and induction of 2',5'-oligoadenylate synthetase in the liver and peripheral blood cells
(
- Contribution to journal › Article